Danish Medicine Council Process Of Assessing New Hospital Medicines – First Year Of Implementation

October 18, 2018 Danielle Twigg

The Danish Medicines Council was established on January 1, 2017. The Council and AMGROS assesses the value of new hospital drugs based on a clinical assessment and categorization of the clinical value using the Grades of Recommendation Assessment, Development and Evaluation system, an economic assessment of the added costs per patient as well as the overall budgetary impact to set a framework for the procurement of the same. The aim of this study was to describe the new process and the outcomes of the recommendations during first year of implementation.

Authors: Dibbern T, Medin E

To find out more about this poster you can register to download it here after the ISPOR event.

Previous Article
Exploring The Impact Of Radiographic Progressive Disease And First Subsequent Therapy On Health State Utility Values
Exploring The Impact Of Radiographic Progressive Disease And First Subsequent Therapy On Health State Utility Values

Next Article
Could ERG Preferences For Different Overall Survival Extrapolation Methodologies Drive Different Nice Appraisal Outcomes?
Could ERG Preferences For Different Overall Survival Extrapolation Methodologies Drive Different Nice Appraisal Outcomes?